How many years of comparable data are there for Burundi and Kenya?

39 years are reported by both, from 1980 to 2018.

Where does this data come from?

World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Burundi vs Kenya: Statin use vs. average non-HDL cholesterol levels

Burundi

2.8

in 2018

Kenya

2.8

in 2018

Burundi rank

163rd

Kenya rank

163rd

Statin use vs. average non-HDL cholesterol levels over time

Burundi
Kenya

How they compare

Burundi currently reports 2.8 against 2.8 in Kenya, a difference of 0.

Across all 39 years both countries report, Kenya has been ahead every year.

Burundi ranks 163rd and Kenya ranks 163rd of 191 countries.

Kenya has averaged higher in every one of the 4 decades both report.

Head to head by decade

Decade	Burundi	Kenya	Difference	Ahead
1980s	2.25	2.38	0.13	Kenya
1990s	2.4	2.52	0.12	Kenya
2000s	2.57	2.64	0.07	Kenya
2010s	2.76	2.77	0.0111	Kenya

Averages of every year both report within each decade.

Frequently asked questions

Which has higher statin use vs. average non-hdl cholesterol levels, Burundi or Kenya?: Burundi, at 2.8 against 2.8 in Kenya as of 2018.
What is the difference in statin use vs. average non-hdl cholesterol levels between Burundi and Kenya?: 0, with Burundi ahead.
How many years of comparable data are there for Burundi and Kenya?: 39 years are reported by both, from 1980 to 2018.
How do Burundi and Kenya rank globally for statin use vs. average non-hdl cholesterol levels?: Burundi ranks 163rd and Kenya ranks 163rd of 191 countries.
Where does this data come from?: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator: Statin use vs. average non-HDL cholesterol levels
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence: CC BY 4.0 (Our World in Data)
Coverage: 191 places, 7,449 data points, 1980–2018
Last refreshed: 07 August 2026

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.